Expression and functional evidence of the prostaglandin F2α receptor mediating contraction in human umbilical vein

European Journal of Pharmacology

Volumn 610, Issue 1-3, 2009, Pages 68-74

  Errasti, Andrea Emilse ^a,b   del Rey, Gianina ^a   Cesio, Cristián Emanuel ^a   Souza, Guadalupe ^a   Nowak, Wanda ^a   Pelorosso, Facundo Germán ^a   Daray, Federico Manuel ^a   Rothlin, Rodolfo Pedro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

AL 8810; Bimatoprost free acid; Human umbilical vein; Latanoprost free acid; PGF2 receptor (prostanoid FP receptor); Prostaglandin F2 (PGF2 ); RT PCR (Reverse transcription polymerase chain reaction); Vasoconstriction; Western blot

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; BIMATOPROST; LATANOPROST; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN; VENOCONSTRICTION;

AMIDES; CLOPROSTENOL; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INFANT, NEWBORN; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDINS F, SYNTHETIC; RECEPTORS, PROSTAGLANDIN; UMBILICAL VEINS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 65049084508     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.022     Document Type: Article

References (54)

1. Abramovitz M., Boie Y., Nguyen T., Rushmore T.H., Bayne M.A., Metters K.M., Slipetz D.M., and Grygorczyk R. Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269 (1994) 2632-2636
2. Abramovitz M., Adam M., Boie Y., Carrière M., Denis D., Godbout C., Lamontagne S., Rochette C., Sawyer N., Tremblay N.M., Belley M., Gallant M., Dufresne C., Gareau Y., Ruel R., Juteau H., Labelle M., Ouimet N., and Metters K.M. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483 (2000) 285-293
3. Adams J.W., Migita D.S., Yu M.K., Young R., Hellickson M.S., Castro-Vargas F.E., Domingo J.D., Lee P.H., Bui J.S., and Henderson S.A. Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J. Biol. Chem. 271 (1996) 1179-1186
4. Altura B.M., Malaviya D., Reich C.F., and Orkin L.R. Effects of vasoactive agents on isolated human umbilical arteries and veins. Am. J. Physiol. 222 (1972) 345-355
5. Anderson L.E., Wu Y.L., Tsai S.J., and Wiltbank M.C. Prostaglandin F (2alpha) receptor in the corpus luteum: recent information on the gene, messenger ribonucleic acid, and protein. Biol. Reprod. 64 (2001) 1041-1047
6. Ansari H.R., Kaddour-Djebbar I., and Abdel-Latif A.A. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter. Exp. Eye Res. 78 (2004) 285-296
7. Ansari H.R., Kaddour-Djebbar I., and Abdel-Latif A.A. Involvement of Ca2+ channels in endothelin-1-induced MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in rabbit iris sphincter smooth muscle. Cell. Signal. 16 (2004) 609-619
8. Arunlakshana O., and Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14 (1959) 48-52
9. Bjøro K., Hovig T., Stokke K.T., and Stray-Pedersen S. Formation of prostanoids in human umbilical vessels perfused in vitro. Prostaglandins 31 (1986) 683-698
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. 2 on some isolated smooth muscle preparations. Br. J. Pharmacol. 73 (1981) 773-778
12. Daray F.M., Minvielle A.I., Puppo S., and Rothlin R.P. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein. Br. J. Pharmacol. 139 (2003) 1409-1416
13. 2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein. Naunyn-Schmiedeberg's Arch. Pharmacol. 373 5 (2006) 367-375 Aug
14. De Groot C.J., Murai J.T., Vigne J.L., and Taylor R.N. Eicosanoid secretion by human endothelial cells exposed to normal pregnancy and preeclampsia plasma in vitro. Prostaglandins Leukot. Essent. Fat. Acids 58 (1998) 91-97
15. Dong Y.J., Jones R.L., and Wilson N.H. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br. J. Pharmacol. 87 (1986) 97-107
16. 1-adrenoceptor subtypes mediating contraction in human umbilical vein. Br. J. Pharmacol. 126 (1999) 437-442
17. Fox S.B., and Khong T.Y. Lack of innervation of human umbilical cord. An inmunohistological and histochemical study. Placenta 11 (1990) 59-62
18. Griffin B.W., Klimko P., Crider J.Y., and Sharif N.A. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J. Pharmacol. Exp. Ther. 290 (1999) 1278-1284
19. Horton E.W., and Poyser N.L. Uterine luteolytic hormone: a physiological role for prostaglandin F2alpha. Physiol. Rev. 56 (1976) 595-651
20. Joy A.P., and Cowley E.A. 8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor. Am. J. Respir. Cell Mol. Biol. 38 (2008) 143-152
21. Kelly C.R., Williams G.W., and Sharif N.A. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost,unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. J. Pharmacol. Exp. Ther. 304 (2003) 238-245
22. Kenakin T.P. The Schild regression in the process of receptor classification.Can. J. Physiol. Pharmacol. 60 (1982) 249-265
23. Kunapuli P., Lawson J.A., Rokach J., and FitzGerald G.A. Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha. J. Biol. Chem. 272 (1997) 27147-27154
24. Kyveris A., Maruscak E., and Senchyna M. Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR. Mol. Vis. 8 (2002) 51-58
25. Makino S., Zaragoza D.B., Mitchell B.F., Yonemoto H., and Olson D.M. Decidual activation: abundance and localization of prostaglandin F2alpha receptor (FP) mRNA and protein and uterine activation proteins in human decidua at preterm birth and term birth. Placenta 28 (2007) 557-565
26. Mandal A.K., Ray R., Zhang Z., Chowdhury B., Pattabiraman N., and Mukherjee A.B. Uteroglobin inhibits prostaglandin F2alpha receptor-mediated expression of genes critical for the production of pro-inflammatory lipid mediators. J. Biol. Chem. 280 (2005) 32897-32904
27. Matsumoto T., Sagawa N., Yoshida M., Mori T., Tanaka I., Mukoyama M., Kotani M., and Nakao K. The prostaglandin E2 and F2 alpha receptor genes are expressed in human myometrium and are down-regulated during pregnancy. Biochem. Biophys. Res. Commun. 238 (1997) 838-841
28. Mewe M., Bauer C.K., Schwarz J.R., and Middendorff R. Mechanisms regulating spontaneous contractions in the bovine epididymal duct. Biol. Reprod. 75 (2006) 651-659
29. Milne S.A., and Jabbour H.N. Prostaglandin (PG) F (2alpha) receptor expression and signaling in human endometrium: role of PGF (2alpha) in epithelial cell proliferation. J. Clin. Endocrinol. Metab. 88 (2003) 1825-1832
30. Neubig R.R., Spedding M., Kenakin T., and Chistopoulus A. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Up-date on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 55 (2003) 597-606
31. Nowak W., Goldschmidt E.D., Falcioni A.G., Pugliese M.I., Errasti A.E., Pelorosso F.G., Daray F.M., Gago J.E., and Rothlin R.P. Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein. Naunyn-Schmiedeberg's Arch. Pharmacol. 375 (2007) 221-229
32. Paredes C., Tazzeo T., and Janssen L.J. E-ring isoprostane augments cholinergic neurotransmission in bovine trachealis via FP prostanoid receptors. Am. J. Respir. Cell. Mol. Biol. 37 (2007) 739-747
33. Pujol-Lereis V.A., Hita F.J., Gobbi M.D., Verdi M.G., Rodriguez M.C., and Rothlin R.P. Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein. Br. J. Pharmacol. 147 (2006) 516-523
34. Reilly F.D., and Russell P.T. Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat. Rec. 188 (1977) 277-286
35. Sales K.J., Milne S.A., Williams A.R., Anderson R.A., and Jabbour H.N. Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways. J. Clin. Endocrinol. Metab. 89 (2004) 986-993
36. Sales K.J., List T., Boddy S.C., Williams A.R., Anderson R.A., Naor Z., and Jabbour H.N. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res. 65 (2005) 7707-7716
37. 1 receptors in human umbilical vein. Eur. J. Pharmacol. 321 (1997) 33-38
38. Schaafsma D., Gosens R., Bos I.S., Meurs H., Zaagsma J., and Nelemans S.A. Role of contractile prostaglandins and Rho-kinase in growth factor-induced airway smooth muscle contraction. Respir. Res. 6 85 (2005) 1-11
39. Schaafsma D., Gosens R., Ris J.M., Zaagsma J., Meurs H., and Nelemans S.A. Insulin induces airway smooth muscle contraction. Br. J. Pharmacol. 150 (2007) 136-142
40. Senior J., Sangha R., Baxter G.S., Marshall K., and Clayton J.K. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium. Br. J. Pharmacol. 107 (1992) 215-221
41. Senior J., Marshall K., Sangha R., and Clayton J.K. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br. J. Pharmacol. 108 (1993) 501-506
42. Sharif N.A. Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro. Prostaglandins Leukot. Essent. Fat. Acids 78 (2008) 199-207
43. Sharif N.A., Williams G.W., and Kelly C.R. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur. J. Pharmacol. 432 (2001) 211-213
44. Sharif N.A., Kelly C.R., and Crider J.Y. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J. Ocular Pharmacol. Ther. 18 (2002) 313-324
45. Sharif N.A., Kelly C.R., Crider J.Y., Williams G.W., and Xu S.X. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J. Ocular Pharmacol. Ther. 19 (2003) 501-515
46. Sharif N.A., Crider J.Y., Husain S., Kaddour-Djebbar I., Ansari H.R., and Abdel-Latif A.A. Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation. J. Ocular Pharmacol. Ther. 19 (2003) 437-455
47. Sharif N.A., Kelly C.R., and Crider J.Y. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. Invest. Ophthalmol. Vis. Sci. 44 (2003) 715-721
48. Smith W.L., Marnett L.J., and DeWitt D.L. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 49 (1991) 153-179
49. Thieme H., Schimmat C., Münzer G., Boxberger M., Fromm M., Pfeiffer N., and Rosenthal R. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest. Ophthalmol. Vis. Sci. 47 (2006) 938-945
50. Toh H., Ichikawa A., and Narumiya S. Molecular evolution of receptors for eicosanoids. 1. FEBS Lett. 361 (1995) 17-21
51. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350-4354
52. Vysniauskiene I., Allemann R., Flammer J., and Haefliger I.O. Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries. Invest. Ophthalmol. Vis. Sci. 47 (2006) 295-298
53. Wanggren K., Lalitkumar P.G., Stavreus-Evers A., Stabi B., and Gemzell-Danielsson K. Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment. Mol. Hum. Reprod. 12 (2006) 577-585
54. Watanabe K., Nagasawa N., Wen F.Q., Inoue K., Kuroda K., and Yoshida M. Azelastine suppresses the release of arachidonic acid metabolites from cultured human umbilical vein endothelial cells. Prostaglandins Leukot. Essent. Fat. Acids 56 (1997) 209-211